Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-09-20

FDA Approved: CEQUA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Cequa (cyclosporine ophthalmic solution) from Sun Pharmaceutical Industries. The action updates the product labe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cequa (cyclosporine ophthalmic solution)

Snippet

SUPPL AP for CEQUA (CYCLOSPORINE)